Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical study Independent interim analysis of the E.mbrace phase 3 study finds that the vaccine candidate didn't demonstrate sufficient ...

Update on extraintestinal pathogenic E. coli vaccine phase 3 clinical studyIndependent interim analysis of the E.mbrace phase 3 study finds that ...

Reports Q2 revenue $1.11M vs $1.24M last year. Eric A. Adams, InMed’s Chief Executive Officer, commented, “We are pleased with the steady ...

Rep. August Pfluger hosted U.S. Energy Secretary Chris Wright on Tuesday as part of a Republican Study Committee meeting, of which the congressman is the chairman. “House Republicans know that ...

Josh Bradley is Creative Loafing Tampa's resident live music freak. He started freelancing with the paper in 2020 at the age of 18, and has since covered, announced, and previewed numerous live shows ...

The Capitals netminder talks his favorite saves to make, hockey terminology and his intense hydration routine.

Rep. Ayanna Pressley will reintroduce H.R. 40, federal legislation to study reparations for slavery, on Wednesday as the ...

Achieving a digital transition that strengthens Europe's strategic competitiveness means addressing the persistent challenges in innovation, adoption, and technological dependency.

Andy Kaufman documentary 'Thank You Very Much' is executive produced by Morgan Neville and Josh and Benny Safdie.

Kishor Koladia and Sam Kumar are bullish on the El Paso hotel market and are showing their confidence with several new hotel ...

Study Group will be back with high-octane action on the second last week of its completion. Read to know where to watch it and what all to expect.

ORIC Pharmaceuticals (NASDAQ:ORIC – Get Free Report)‘s stock had its “buy” rating reaffirmed by analysts at Guggenheim in a research report issued to clients and investors on Monday,Benzinga reports.